Literature DB >> 6260141

Purification and characterization of small molecular weight myeloperoxidase from human promyelocytic leukemia HL-60 cells.

M Yamada, M Mori, T Sugimura.   

Abstract

Human myeloperoxidase was purified to homogeneity from human promyelocytic leukemia HL-60 cells. A small molecular weight myeloperoxidase was found in these cells and was separated from three other forms of myeloperoxidase of large molecular weight by carboxymethyl-Sepharose CL-6B column chromatography and Sephacryl S-200 gel filtration. The S20,w values of the molecular weights of the small and large myeloperoxidases were found to be 5.2 and 8.07 S, respectively, by sucrose density gradient centrifugation. From these S20,w values, the molecular weights of the small and large myeloperoxidases were estimated to be 79 000 and 153 000, respectively. On electrophoresis in sodium dodecyl sulfate--polyacrylamide gel, the small and large myeloperoxidases each gave two bands of protein corresponding to molecular weights of 59 300 and 10 150. The small myeloperoxidase could not be distinguished from the large enzymes by the Ouchterlony double immunodiffusion test, but it could be distinguished from them by the microcomplement fixation text. One of the three large molecular weight myeloperoxidases was eluted at a lower concentration of methyl alpha-D-mannoside than the other two on concanavalin A--Sepharose chromatography. This suggested that the heterogeneity of the myeloperoxidases with large molecular weight may be partly due to differences in their sugar moieties.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260141     DOI: 10.1021/bi00507a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Myeloperoxidase: a myeloid cell nuclear antigen with DNA-binding properties.

Authors:  S Murao; F J Stevens; A Ito; E Huberman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections.

Authors:  M C Gallicchio; J A Savige
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

3.  Studies on the subunits of human myeloperoxidase.

Authors:  R L Olsen; C Little
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

4.  Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species.

Authors:  K R Johnson; W M Nauseef; A Care; M J Wheelock; S Shane; S Hudson; H P Koeffler; M Selsted; C Miller; G Rovera
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

5.  Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

Authors:  K T Miyasaki; J J Zambon; C A Jones; M E Wilson
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Peroxidase and peroxidase-oxidase activities of isolated human myeloperoxidases.

Authors:  B E Svensson; K Domeij; S Lindvall; G Rydell
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

7.  Protein arginine deiminase 4: a target for an epigenetic cancer therapy.

Authors:  Jessica L Slack; Corey P Causey; Paul R Thompson
Journal:  Cell Mol Life Sci       Date:  2010-08-13       Impact factor: 9.261

8.  Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system.

Authors:  K T Miyasaki; M E Wilson; R J Genco
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

9.  Isolation of a sodium transport inhibitory factor, inhibitin, from cultured leukemic promyelocytes.

Authors:  K Morgan; M A Mir
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.

Authors:  W M Nauseef; R K Root; H L Malech
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.